Anti-PSGL-1 antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S130100, C424S133100, C424S141100, C424S143100, C424S144100, C424S152100, C424S153100, C424S172100, C424S173100, C530S387100, C530S387300, C530S388100, C530S388200, C530S388220, C530S388700, C530S388730, C530S388750

Reexamination Certificate

active

07604800

ABSTRACT:
Immunoglobulin chains or antibodies having light or heavy chain complementarity determining regions of antibodies that bind to P-Selectin Glycoprotein Ligand-1. Also disclosed are methods of inducing death of an activated T-cell and of modulating a T cell-mediated immune response in a subject.

REFERENCES:
patent: 5378464 (1995-01-01), McEver
patent: 5618785 (1997-04-01), Heavner et al.
patent: 5709859 (1998-01-01), Aruffo et al.
patent: 5710123 (1998-01-01), Heavner et al.
patent: 5808025 (1998-09-01), Tedder et al.
patent: 5827817 (1998-10-01), Larsen et al.
patent: 5834425 (1998-11-01), Tedder et al.
patent: 5840679 (1998-11-01), Larsen et al.
patent: 5843707 (1998-12-01), Larsen et al.
patent: 5852175 (1998-12-01), Cummings et al.
patent: 5972625 (1999-10-01), Rosen et al.
patent: 6056956 (2000-05-01), Cobbold et al.
patent: 6124267 (2000-09-01), McEver et al.
patent: 6309639 (2001-10-01), Cummings et al.
patent: 6348581 (2002-02-01), Anderson et al.
patent: 6667036 (2003-12-01), Cummings et al.
patent: 6884619 (2005-04-01), Hockfield et al.
patent: 2002/0164336 (2002-11-01), Harrison et al.
patent: 2003/0049252 (2003-03-01), Lin et al.
patent: 2004/0001839 (2004-01-01), Levanon et al.
patent: 2004/0002450 (2004-01-01), Lazarovits et al.
patent: WO 97/06176 (1997-02-01), None
patent: WO 00/25808 (2000-05-01), None
patent: WO 03/013603 (2003-02-01), None
Rudikoff et al. Proc Natl Acad Sci USA 79: 1979-1983,1982.
Colman, Research in Immunology 145: 33-36, 1994.
Battistini, et al. “CD8+ T cells from 1-37 patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: A critical role for P-selectin glycoprotein ligand-1.”Blood, vol. 101, No. 12, 4775-4782 (Jun. 15, 2003).
Beckwith et al., “The Protein Product of the Proto-oncogene c-cbl Forms a Complex With Phosphatidylinositol 3-Kinase p85 and CID 19 in Anti-IgM Stimulated Human B-Lymphoma Cells,”Blood88(9):3502-3507, (1996).
Besnault et al., “B Cell Receptor Cross-Linking Triggers a Caspase-8-Dependent Apoptotic Pathway That Is Independent of the Death Effector Domain of Fas-Associated Death Domain Protein,”J. Immunol., 167:733-740, (2001).
Borges et al., “P-Selectin Glycoprotein Ligand-1 (PSGL-1) on T Helper 1 but Not on T Helper 2 Cells Binds to P-Selectin and Supports Migration into Inflamed Skin,”J. Exp. Med. 185(3):573-578 (Feb. 3, 1997).
Borges et al., “The Binding of T Cell-expressed P-selectin Glycoprotein Ligand-1 to E- and P-selectin Is Differentially Regulated,”J. Biol. Chem. 272(45):28786-28792 (Nov. 7, 1997).
Diacovo, et al. “Interactions of human alpha/beta and gamma/delta T lymphocyte subsets in shear flow with E-seelctin and P-selectin.”J. Exp. Med., vol. 183, 1193-1203 (Mar. 1996).
Dimitroff, et al. “Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: Implications in modulating lymphocyte migration to skin.”Blood, vol. 101, No. 2, 602-610 (Jan. 15, 2003).
Evangelista et al., “Platelet/Polymorphonuclear Leukocyte Interaction: P-Selectin Triggers Protein-Tyrosine Phosphorylation-Dependent CD11b/CD 18 Adhesion: Role ofPSGL-1 as a Signaling Molecule,”Blood93(3):876-885 (Feb. 1, 1999).
Faraday et al., “Leukocytes Can Enhance Platelet-mediated Aggregation and Thromboxane Release via Interaction of P-selectin Glycoprotein Ligand 1 with P-selectin,”Anesthesiology94(1):145-151 (Jan. 2001).).
Frenette et al., “P-Selectin Glycoprotein Ligand 1 (PSGL-1) Is Expressed on Platelets and Can Mediate Platelet-Endothelial Interactions In Vivo,”J. Exp. Med. 191(8):1413-1422 (Apr. 17, 2000).
Fuhlbrigge et al., “Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells,”Nature389:978-981 (Oct. 1997).
Herron MJ et al., Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1.Science. Jun. 2, 2000;288(5471):1653-6.
Hirata et al., “P-Selectin Glycoprotein Ligand 1 (PSGL-1) Is a Physiological Ligand for E-Selectin in Mediating T Helper 1 Lymphocyte Migration,”J. Exp. Med. 192(11):1669-1675 (Dec. 4, 2000).
Hirose et al., “A functional epitope on P-selectin that supports binding of P-selectin to P-selectin glycoprotein ligand-1 but not to sialyl Lewis X oligosaccharides,”Internatl. Immunol. 10(5):639-649 (Jan. 26, 1998).
Igarashi et al., “Telomerase Activity Is Induced in Human Peripheral B Lymphocytes by the Stimulation to Antigen Receptor,”Blood, 89(4):1299-1307, (1997).
Kaytes, et al. “P-selectin mediates 1-37 adhesion of the human melanoma cell line NKI-4: Identification of glycoprotein ligands.”Biochemistry, vol. 37, No. 29, 10514-10521 (Jul. 21, 1998).
Kieffer, et al. “Neutrophilis, monocytes, and dendritic cells express the same specialized form of PSGL-1 as do skin-homing memory T cells: Cutaneous lymphocyte antigen.”Biochem. Biophys. Res. Comm., vol. 285, No. 3, 577-587 (Jul. 20, 2001).
Laszik et al., “P-Selectin Glycoprotein Ligand-1 Is Broadly Expressed in Cells of Myeloid, Lymphoid, and Dendritic Lineage and in Some Nonhematopoietic Cells,”Blood88(8):3010-3021 (Oct. 15, 1996).
Levesque et al., “PSGL-1-Mediated Adhesion of Human Hematopoietic Progenitors to P-Selectin Results in Suppression of Hematooiesis,”Immunity11:369-378 (Sep. 1999).
Li et al., “Visualization of P-Selectin Glycoprotein Ligand-1 As A Highly Extended Molecule and Mapping of Protein Epitopes for Monoclonal Antibodies,”J. Biol.Chem. 271(11):6342-6348 (1996).
Moore et al., “P-Selectin Glycoprotein Ligand-1 Mediates Rolling of Human Neutrophils on P-Selectin,”J. Cell Biol. 128(4):661-671 (1995).
Sako D et al., Expression cloning of a functional glycoprotein ligand for P-selectin.Cell. Dec. 17, 1993;75(6):1179-86.
Shan et al., “Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies,”Blood, 91(5):1644-1652, (1998).
Snapp et al., “A Novel P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Recognizes an Epitope Within the Tyrosine Sulfate Motif of Human PSGL-1 and Blocks Recognition of Both P- and L-Selectin,”Blood91(1):154-164 (Jan. 1, 1998).
Stockmeyer et al., “Polymorphonuclear Granulocytes Induce Antibody-Dependent Apoptosis in Human Breast Cancer Cells,”J. Immunol., 171:5124-5129, (2003).
Trembleau, et al., “Pancreas-Infiltrating Th1 Cells and Diabetes Develop in IL-12 Deficient Nonobese Diabetic Mice,”J. Immunol. 163:2960-2968 1999).
Vachino G et al., P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells.J. Biol Chem. Sep. 15, 1995;270(37):21966-74.
Veldman GM et al., Genomic organization and chromosomal localization of the gene encoding human P-selectin glycoprotein ligand.J Biol Chem. Jul. 7, 1995;270(27):16470-5.
Wing et al., “Mechanism of First-Dose Cytokine-Release Syndrome by CAMPATH 1-H: Involvement of CD16 (FcyRlll) and CD11a/CD18 (LFA-1) on NK Cells,”J. Clin. Invest. 98(12):2819-2826 (1996).
Woltmann, et al. “Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow.”Blood, vol. 95, No. 10, 3146-3152 (May 15, 2000).
Wu et al., “Role of P-Selectin and Anti-P-Selectin Monoclonal Antibody in Apoptosis During Hepatic/Renal Ischemia Reperfusion Injury,”World J. Gastroentero6(2):244-247 (2000).
Yago et al., “IL-12 Promotes the Adhesion of NK Cells to Endothelial Selectins Under Flow Conditions,”J. Immunol. 161:1140-1145 (1998).
Yang et al., “Targeted Gene Disruption Demonstrates That P-Selectin Glycoprotein Ligand 1 (PSGL-1) Is Required for P-Selectin-mediated but Not E-Selectin-mediated Neutrophil Rolling and Migration,”J. Exp. Med. 190(12):1769-1782 (De

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-PSGL-1 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-PSGL-1 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-PSGL-1 antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4088177

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.